These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27879198)

  • 1. Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
    Kandela I; Chou J; Chow K;
    Elife; 2015 May; 4():. PubMed ID: 27879198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
    Kandela I; Chou J; Chow K; ;
    Elife; 2015 May; 4():. PubMed ID: 25998055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
    Mantis C; Kandela I; Aird F;
    Elife; 2017 Jan; 6():. PubMed ID: 28100395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.
    Peng ZH; Kopeček J
    J Am Chem Soc; 2015 Jun; 137(21):6726-9. PubMed ID: 25963409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
    Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
    Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
    Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
    Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
    Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
    Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
    Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells.
    Vanden Heuvel JP; Bullenkamp J;
    Elife; 2016 Jun; 5():. PubMed ID: 27336789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registered report: Melanoma genome sequencing reveals frequent PREX2 mutations.
    Chroscinski D; Sampey D; Hewitt A;
    Elife; 2014 Dec; 3():. PubMed ID: 25490935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
    Khan I; Kerwin J; Owen K; Griner E; ;
    Elife; 2015 Sep; 4():. PubMed ID: 26335297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data.
    Kandela I; Zervantonakis I; ;
    Elife; 2015 May; 4():e06847. PubMed ID: 25939392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.
    Sha H; Zou Z; Xin K; Bian X; Cai X; Lu W; Chen J; Chen G; Huang L; Blair AM; Cao P; Liu B
    J Control Release; 2015 Feb; 200():188-200. PubMed ID: 25553823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
    Blum D; LaBarge S;
    Elife; 2014 Dec; 3():. PubMed ID: 25490933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
    Li J; Lam M;
    Elife; 2015 Jul; 4():e06434. PubMed ID: 26231042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.
    Fiering S; Ang LH; Lacoste J; Smith TD; Griner E;
    Elife; 2015 Jul; 4():e04796. PubMed ID: 26179155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
    Bhargava A; Pelech S; Woodard B; Kerwin J; Maherali N; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26882073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.